Galecto Inc (GLTO) Stock Analysis

Galecto Inc (GLTO) is a publicly traded company in the HEALTHCARE sector. It trades at $24.85. This page summarizes the public market data, fundamentals, and frequently asked questions for GLTO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $24.85

Market Sentiment

Galecto Inc currently has a Neutral sentiment score of 0.04.

About Galecto Inc

Galecto, Inc. is a clinical-stage biotechnology firm headquartered in Copenhagen, Denmark, dedicated to developing advanced therapeutic solutions for significant unmet medical needs in fibrosis, cancer, and inflammation. Leveraging its proprietary galectin technology platform, the company is strategically positioned to target critical biological pathways associated with these diseases, enhancing its potential to deliver groundbreaking treatments. With a strong pipeline of drug candidates, Gal...

GNG Research Analysis

GNG Research scores Galecto Inc (GLTO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GLTO.

Frequently Asked Questions

Does GLTO pay dividends?

Galecto Inc (GLTO) does not currently pay a regular dividend.